In the recent study, we claimed the identification plus the characterization of a whole new atypical opioid receptor with exclusive adverse regulatory properties in direction of opioid peptides.1 Our results showed that ACKR3/CXCR7, hitherto called an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is usually a broad-spectrum scavenger https://rogerk516vbg9.wizzardsblog.com/profile